Safety and Antitumor Activity of Farletuzumab Ecteribulin in Patients With NSCLC: Phase I Expansion Results.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/6E2CB9B2.svg?ark=w1%2F20260515%2F6E2CB9B2)](https://nobleid.org/work/w1/20260515/6E2CB9B2)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors